A novel framework to quantify uncertainty in peptide-tandem mass spectrum matches with application to nanobody peptide identification
Nanobodies are small antibody fragments derived from camelids that selectively bind to antigens. These proteins have marked physicochemical properties that support advanced therapeutics, including treatments for SARS-CoV-2. To realize their potential, bottom-up proteomics via liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been proposed to identify antigen-specific nanobodies at the proteome scale, where a critical component of this pipeline is matching nanobody peptides to their begotten tandem mass spectra. While peptide-spectrum matching is a well-studied problem, we show the sequence similarity between nanobody peptides violates key assumptions necessary to infer nanobody peptide-spectrum matches (PSMs) with the standard target-decoy paradigm, and prove these violations beget inflated error rates. To address these issues, we then develop a novel framework and method that treats peptide-spectrum matching as a Bayesian model selection problem with an incomplete model space, which are, to our knowledge, the first to account for all sources of PSM error without relying on the aforementioned assumptions. In addition to illustrating our method's improved performance on simulated and real nanobody data, our work demonstrates how to leverage novel retention time and spectrum prediction tools to develop accurate and discriminating data-generating models, and, to our knowledge, provides the first rigorous description of MS/MS spectrum noise.
Code (0)
등록된 구현이 없습니다.
Tasks
Model SelectionSimilar Papers 제목 키워드 기반
Sequence-to-sequence translation from mass spectra to peptides with a transformer model
A fundamental challenge for any mass spectrometry-based proteomics experiment is the identification of the peptide that generated each acquired tandem mass spectrum. Although approaches that leverage known peptide sequen…
de novo peptide sequencingPepSpecBench: A Unified Evaluation Benchmark for Peptide Tandem Mass Spectrometry Prediction
Tandem mass spectrometry provides a high-throughput framework for identifying and quantifying proteins in complex biological samples. In computational proteomics, predicting peptide MS/MS spectra is a critical task, enab…
Towards Less Biased Data-driven Scoring with Deep Learning-Based End-to-end Database Search in Tandem Mass Spectrometry
Peptide identification in mass spectrometry-based proteomics is crucial for understanding protein function and dynamics. Traditional database search methods, though widely used, rely on heuristic scoring functions and st…
Contrastive LearningDecoderImproving the Results of De novo Peptide Identification via Tandem Mass Spectrometry Using a Genetic Programming-based Scoring Function for Re-ranking Peptide-Spectrum Matches
De novo peptide sequencing algorithms have been widely used in proteomics to analyse tandem mass spectra (MS/MS) and assign them to peptides, but quality-control methods to evaluate the confidence of de novo peptide sequ…
de novo peptide sequencingRe-RankingPep2Prob Benchmark: Predicting Fragment Ion Probability for MS$^2$-based Proteomics
Proteins perform nearly all cellular functions and constitute most drug targets, making their analysis fundamental to understanding human biology in health and disease. Tandem mass spectrometry (MS$^2$) is the major anal…